📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS. (2020)

First Author: Tsourdi E
Attributed to:  Centre for Integrated research into Musculoskeletal Ageing (CIMA) Renewal funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1210/clinem/dgaa756

PubMed Identifier: 33103722

Publication URI: http://europepmc.org/abstract/MED/33103722

Type: Journal Article/Review

Parent Publication: The Journal of clinical endocrinology and metabolism

ISSN: 0021-972X